ScolioLife CEO Dr. Kevin Lau Appointed United Nations Representative to ECOSOC

Press Release · Singapore · May 7, 2026 · ScolioLife Newsroom

SINGAPORE — ScolioLife®, Asia’s leading specialist chiropractic and physiotherapy clinic for non-surgical scoliosis correction, today announced that its CEO and Founder, Dr. Kevin Lau, has been formally appointed as a United Nations Representative to the Africana Women Working Group (AWWG) at the United Nations Economic and Social Council (ECOSOC) for the calendar year 2026. The appointment, effective April 1 through December 31, 2026, positions ScolioLife at an international advocacy platform spanning over 190 member states — and marks a pivotal step in the clinic’s mission to elevate spine health as a measurable public health issue.

Access to the Highest Levels of Global Health Dialogue

As an authorised UN Representative, Dr. Lau is now cleared to participate in a series of high-level UN processes on behalf of the AWWG ECOSOC NGO — including the ECOSOC Youth Forum, the Commission on the Status of Women, the Commission on Social Development, the Commission on Population and Development, and the UN High-Level Political Forum on Sustainable Development. He is further authorised to contribute to policy dialogues, statements, and reports, and to apply — through the ECOSOC NGO platform — to host parallel or side events at UN sessions.

This access is not ceremonial. ECOSOC forums are where governments, civil society organisations, and health bodies shape the frameworks that influence national health policies, research funding priorities, and disability classification standards — the same frameworks that currently leave an estimated 80% of adolescent scoliosis cases worldwide undetected until they require surgery or lifelong bracing.

Scoliosis: A Silent Epidemic Without a Global Health Mandate

Scoliosis affects an estimated 2–3% of the global population — approximately 165 million people. In Asia, the condition disproportionately impacts adolescent girls during critical growth phases, with studies across Singapore, Malaysia, and Indonesia showing screening rates that fall well below World Health Organization benchmarks for early detection. Despite this scale, scoliosis has no dedicated global health resolution, no internationally standardised early screening protocol, and no entry in the UN Sustainable Development Goal health metrics.

The human cost is compounded by economics. In Southeast Asia, surgical intervention for progressive scoliosis commonly costs between SGD 60,000 and SGD 120,000 — pricing it beyond reach for the majority of families in Malaysia and Indonesia. Non-surgical correction, when initiated early, aims to achieve clinically measurable curve improvement at a fraction of that cost. The evidence base is growing. What has been absent is a voice at the table where health policy is written.

“Scoliosis is not a rare disease. It is a common condition that has been invisible in global health policy for too long. This appointment gives us a seat at the table where that changes.”
— Dr. Kevin Lau, CEO & Founder, ScolioLife®

What This Means for Patients in Singapore, Malaysia, and Indonesia

For ScolioLife’s patient communities across three clinic locations, this appointment carries concrete implications. Dr. Lau’s participation in UN policy forums opens pathways to advocate for:

• Mandatory adolescent scoliosis screening in school health programmes across the region.
• Inclusion of non-surgical scoliosis correction in national healthcare subsidy frameworks.
• Formal recognition of the ScolioLife® Method — the hyper-corrective ScolioAlign® brace combined with customised scoliosis-specific exercises — as an evidence-informed clinical standard.

In Indonesia, where the Surabaya clinic serves patients from across Java and Eastern Indonesia, the policy gap is particularly acute. There is currently no national scoliosis screening mandate for schools, and most rural families first encounter the diagnosis only after a curve has progressed beyond 40 degrees — the surgical threshold. Dr. Lau’s voice at ECOSOC’s Commission on Social Development will specifically address equity-of-access issues affecting healthcare delivery in lower-income populations across the ASEAN region.

About Dr. Kevin Lau

Dr. Kevin Lau is the founder and CEO of ScolioLife® Pte Ltd, a specialist chiropractic and physiotherapy clinic group operating in Singapore, Kuala Lumpur, and Surabaya. He is the developer of the ScolioLife® Method — a non-surgical scoliosis correction protocol combining structural bracing with individualised exercise therapy — and the author of multiple published works on scoliosis management. Dr. Lau holds clinical credentials in chiropractic and has dedicated over two decades to building a clinical and public education framework around non-surgical spine correction across Asia. His appointment to the AWWG at ECOSOC follows his recent appointment to the Forttuna Health and Wellness Council.

About the AWWG and ECOSOC

The Africana Women Working Group (AWWG) is a civil society organisation holding ECOSOC consultative status at the United Nations. ECOSOC — the UN Economic and Social Council — is the principal body coordinating economic, social, and environmental work across the UN system, engaging over 2,900 registered NGOs. As an ECOSOC-accredited NGO, the AWWG can participate in ECOSOC sessions, submit statements, and host parallel events at key UN forums. Appointed representatives serve as the voice of the organisation within the UN system.

This announcement was originally distributed via EIN Presswire on May 7, 2026. View the original release. Media contact: drkevinlau@scoliolife.com · +65 8907 8900.

Frequently Asked Questions

Early Detection Changes Outcomes

The earlier a curve is identified, the more non-surgical options are available. ScolioLife screens and supports patients of all ages across three clinics.